rethinks
-
ADM rethinks scope of $300M plant-based investment after slow earnings
Dive Brief: Archer Daniels Midland is changing course on a $300 million plan to expand production of alternative proteins as…
Read More » -
ADM rethinks scope of $300M plant-based investment
Dive Brief: Archer Daniels Midland is changing course on a $300 million plan to expand production of alternative proteins as…
Read More » -
Taking pulse on private biotech funding; Q&A with Isomorphic Labs CEO; Research institutions rethinks dealmaking; and more – Endpoints News
WelÂcome back to EndÂpoints WeekÂly, your reÂview of the week’s top bioÂpharÂma headÂlines. Want this in your inÂbox every SatÂurÂday…
Read More »